Age: 46 Executive Since 2007 Ph.D
The company has return on total asset (ROA) of 10.89 % which means that it generated profit of $10.89 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 15.06 % meaning that it created $15.06 on every $100 dollars invested by stockholders.
PCYC price boundaries
Entity SummaryPharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes smallmolecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. Pharmacyclics Inc [PCYC] is traded on NASDAQ in USA. It is located in Sunnyvale, CA and employs 484 people.
Filter other executives
Pharmacyclics IncUSA StockCurrency: USD - US DollarTraded on NASDAQ
Fix Your Portfolios with PCYC
Promote PCYC and Joseph Buggy
Use alpha and beta coefficients to find investment opportunities after accounting for the riskFind Alpha
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and familiesResearch Equities
Find insiders across different sectors to evaluate their impact on performance and growth of their entitiesResearch Insiders